Let the bidding war begin: Teva makes unsolicited offer for NuPathe
January 08, 2014 at 09:15 AM EST
NuPathe Inc. has suddenly become the target of a bidding war. The Malvern, Pa., biopharmaceutical company disclosed Wednesday in a filing with the Securities & Exchnage Commission that it has received an unsolicited $114 million acquisition proposal from Teva Pharmaceuticals Industries...